Comparative evaluation of authorized drugs for treating Covid‐19 patients
Abstract Background and Aims Vaccines are the first line of defense against coronavirus disease 2019 (Covid‐19). However, the antiviral drugs provide a new tool to fight the Covid‐19 pandemic. Here we aimed for a comparative evaluation of authorized drugs for treating Covid‐19 patients. Methods We s...
Main Authors: | Towhidul Islam, Moynul Hasan, Mohammad Saydur Rahman, Md. Rabiul Islam |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-07-01
|
Series: | Health Science Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/hsr2.671 |
Similar Items
-
Interactions of the Anti-SARS-CoV-2 Agents Molnupiravir and Nirmatrelvir/Paxlovid with Human Drug Transporters
by: Éva Bakos, et al.
Published: (2023-07-01) -
Potential herb–drug interactions between anti-COVID-19 drugs and traditional Chinese medicine
by: Ling Ye, et al.
Published: (2023-09-01) -
Thymoquinone’s Antiviral Effects: It is Time to be Proven in the Covid-19 Pandemic Era and its Omicron Variant Surge
by: Maen Abdelrahim, et al.
Published: (2022-04-01) -
Absolute Risk Reductions in COVID-19 Antiviral Medication Clinical Trials
by: Ronald B. Brown
Published: (2023-03-01) -
Mild COVID- 19 infection: Do we have any effective drugs? A narrative review
by: Deependra K Rai, et al.
Published: (2022-01-01)